IN2014MN01513A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01513A
IN2014MN01513A IN1513MUN2014A IN2014MN01513A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A IN 1513MUN2014 A IN1513MUN2014 A IN 1513MUN2014A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A
Authority
IN
India
Prior art keywords
subject
allergic
peptides
timothy grass
methods
Prior art date
Application number
Other languages
English (en)
Inventor
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Original Assignee
Jolla Inst Allergy Immunolog
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog, Alessandro Sette, Veronique Schulten, Howard Grey, Bjoern Peters, Jason Greenbaum filed Critical Jolla Inst Allergy Immunolog
Publication of IN2014MN01513A publication Critical patent/IN2014MN01513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IN1513MUN2014 2012-02-07 2013-02-07 IN2014MN01513A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
IN2014MN01513A true IN2014MN01513A (de) 2015-09-11

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1513MUN2014 IN2014MN01513A (de) 2012-02-07 2013-02-07

Country Status (13)

Country Link
US (1) US10428124B2 (de)
EP (1) EP2812026A4 (de)
JP (1) JP2015513527A (de)
KR (1) KR20140129124A (de)
CN (1) CN104203277A (de)
AU (1) AU2013216993C1 (de)
BR (1) BR112014019504A2 (de)
CA (1) CA2864084A1 (de)
EA (1) EA201491481A1 (de)
HK (1) HK1204929A1 (de)
IN (1) IN2014MN01513A (de)
MX (1) MX2014009285A (de)
WO (1) WO2013119863A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
US20160287696A1 (en) 2013-11-20 2016-10-06 La Jolla Institute For Allergy And Immunology Pan pollen immunogens and methods and uses for immune response modulation
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
BR112016011930A2 (pt) 2013-12-23 2017-09-26 Alk Abello As combinações de peptídeos e seus usos em tratamento de alergia de ácaro de poeira
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
BR112017006969A2 (pt) 2014-10-07 2017-12-19 Cytlimic Inc peptídeo derivado de hsp70, composição farmacêutica para o tratamento ou a prevenção de câncer usando o mesmo, indutor de imunidade e método de produção de célula apresentadora de antígeno
CN107428815B (zh) 2015-03-09 2021-07-09 Cytlimic公司 源于gpc3的肽、使用其的用于治疗或预防癌症的医药组合物、免疫诱导剂、及抗原呈递细胞的制造方法
ES2844049T3 (es) 2015-04-07 2021-07-21 Cytlimic Inc Adyuvante para vacunas contra el cáncer
RU2759728C2 (ru) 2016-10-11 2021-11-17 Ситлимик Инк. Лекарственное средство
EP3617312A4 (de) * 2017-04-28 2021-04-07 Hoyu Co., Ltd. Allergieantigen und epitop dafür

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
BR0312068A (pt) * 2002-06-25 2005-03-29 Merck Patent Ges Mit Beschaenk Sequência de dna e preparação de alérgeno de pólen de gramìneas phl p 4 por métodos recombinantes
US7731970B2 (en) 2002-08-19 2010-06-08 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
EP2489726A3 (de) 2005-01-12 2012-11-28 Monsanto Technology LLC Gene und ihre Verwendung zur Pflanzenverbesserung
EP3097927B1 (de) * 2008-02-01 2023-05-03 Murdoch Childrens Research Institute Verfahren zur induktion von toleranz gegenüber einem allergen
EP2388268A1 (de) * 2010-05-18 2011-11-23 Stallergenes S.A. Rekombinantes, in Pichia pastoris als natürliches Allergen exprimiertes Der-p-2 zur Immuntherapie und für Diagnosezwecke
EP2987501A1 (de) 2010-10-15 2016-02-24 Alk-Abelló A/S Unterdrückung einer überempfindlichkeitsimmunreaktion mit unzusammenhängendem antigen aus allergenem ausgangsmaterial
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
AU2013240271A1 (en) * 2012-03-26 2014-10-02 Axcella Health Inc. Nutritive fragments, proteins and methods
EA029009B1 (ru) 2012-04-16 2018-01-31 Альк-Абелло А/С Применение полипептида профилина растений в неспецифической иммунотерапии аллергии

Also Published As

Publication number Publication date
BR112014019504A2 (pt) 2017-06-27
US20150023992A1 (en) 2015-01-22
HK1204929A1 (en) 2015-12-11
EA201491481A1 (ru) 2014-11-28
EP2812026A1 (de) 2014-12-17
CN104203277A (zh) 2014-12-10
AU2013216993B2 (en) 2016-09-15
JP2015513527A (ja) 2015-05-14
MX2014009285A (es) 2015-02-04
AU2013216993A1 (en) 2014-08-21
CA2864084A1 (en) 2013-08-15
WO2013119863A1 (en) 2013-08-15
EP2812026A4 (de) 2016-04-27
US10428124B2 (en) 2019-10-01
AU2013216993C1 (en) 2017-01-19
KR20140129124A (ko) 2014-11-06

Similar Documents

Publication Publication Date Title
IN2014MN01513A (de)
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
MX2019011952A (es) Proteina anti-garp y sus usos.
HK1216487A1 (zh) 具有穩定的乳液體系的基於氨基酸和蛋白水解物的配方食品
EA201590451A1 (ru) Способ лечения меланомы с применением вируса простого герпеса и ингибитора иммунной контрольной точки
SG194755A1 (en) Pre-fusion rsv f antigens
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
EA201790109A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
BR112013020500A2 (pt) anticorpo isolado, recombinante ou purificado
BR112015013127A2 (pt) imunoterapia com agentes de ligação
MX348071B (es) Variantes de fc.
BR112016011025A2 (pt) polipeptídeos anticorpo e seus usos
WO2011113019A3 (en) Ctla4 proteins and their uses
IN2014CN04498A (de)
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
BR112013018742A2 (pt) cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profilática
MX2015012428A (es) Tratamiento contra enfermedades mediadas th2 por inhibicion de bromodominios.
PH12014502352A1 (en) Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition
EP3087185A4 (de) Antikörper mit c-terminalen leichtkettepolypeptiderweiterungen und konjugaten sowie verfahren zur verwendung davon
WO2016131000A3 (en) Tolerance therapeutic for treating polypeptide induced allergy
PH12015501870B1 (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
WO2011123858A3 (en) Ccn3 peptides and analogs thereof for therapeutic use
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos